Longevity
NAD+
Nicotinamide adenine dinucleotide · coenzyme · energy
A cellular-energy coenzyme sold as an injectable/IV boost for brain energy and longevity — real biochemistry, thin direct human trial support at the doses marketed.
Reference status
Editorial research · independent review pending · 3 claims graded
What it is
NAD+ is a coenzyme every cell needs for energy metabolism, and levels are known to decline with age. This basic biology is not in dispute and is why NAD+ (and its precursors, NMN and NR) has become a major longevity-supplement category.
The gap is between 'NAD+ levels matter for cellular energy' (well established) and 'injecting or IV-infusing NAD+ meaningfully boosts brain energy or extends healthy lifespan in humans' (largely unproven — most human trials so far use oral precursors, at different doses, with modest and mixed results).
The science, graded
What’s claimed — and how strong the evidence behind each claim actually is.
“Supports cellular energy metabolism”
The underlying biochemistry is solid; human trials of NAD+ precursors show measurable blood-level increases.
Claim-level citation mapping is in progress.
“Boosts brain energy and mental clarity”
Widely reported after IV sessions; hard to separate from placebo/infusion-visit effects in uncontrolled settings.
Claim-level citation mapping is in progress.
“A proven longevity intervention”
No human lifespan or healthspan trial has demonstrated this for injectable/IV NAD+ specifically.
Claim-level citation mapping is in progress.
Legal and regulatory context
Separate summaries for Great Britain, the United States, and the European Union. These are preliminary research summaries awaiting independent regional review; they are not legal determinations or advice.
Great Britain
Not a licensed medicine in the UK. IV/injectable NAD+ is offered by some private wellness clinics, but this sits outside standard medicines regulation — it is not a regulated therapeutic service.
This is preliminary regulatory research, not a reviewed legal determination or legal advice.
United States
Regional legal and regulatory review required before publication.
This is preliminary regulatory research, not a reviewed legal determination or legal advice.
- FDA's Concerns About Unapproved Drugs · U.S. Food and Drug Administration
European Union
Regional legal and regulatory review required before publication.
This is preliminary regulatory research, not a reviewed legal determination or legal advice.
- Buying medicines online · European Medicines Agency
What the community says
Heavily marketed through private IV-drip clinics as much as peptide forums. Enthusiasm is high; more sceptical voices point out how far the direct evidence lags the marketing.
Where they’re talking
- Longevity forumsFrequently compared with oral NMN/NR precursors.
- Wellness-clinic reviewsAnecdotal energy reports dominate; little discussion of trial data.
References
- 1.Supply unlicensed medicinal products (specials) · MHRA
- 2.FDA's Concerns About Unapproved Drugs · U.S. Food and Drug Administration
- 3.Buying medicines online · European Medicines Agency